Cns Pharmaceuticals Inc (CNSP) - News Archive

In recent news, CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a leading biopharmaceutical company specializing in the development of innovative anti-cancer drug candidates, is set to participate in the upcoming Virtual Inves...

CNS Pharmaceuticals Inc (NASDAQ:CNSP), a Houston-based biopharmaceutical company focusing on cancer treatments for the brain and central nervous system, has experienced significant challenges in recent months. The compa...

In recent months, CNS Pharmaceuticals Inc. (NASDAQ:CNSP) has been making waves in the biopharmaceutical industry with announcements and developments that have captured the attention of investors and healthcare professio...

Intro:Cns Pharmaceuticals Inc (NASDAQ: CNSP) shares have failed to match the overall market performance with a year-to-date (YTD) decline of 15.15%. Despite some recent developments and positive news, the company contin...

:CNS Pharmaceuticals Inc (NASDAQ: CNSP) is a clinical-stage biopharmaceutical company with a mission to develop innovative treatments for primary and metastatic cancers of the brain and central nervous system. This arti...

CNS Pharmaceuticals Inc (NASDAQ: CNSP) has been experiencing a decline in its stock price, with a significant drop of -22.93% compared to its last closing price of 3.62. Despite this recent decrement, the company has fa...